However, tumor cells from one SBT case stained positive for p53 (an indication of mutant TP53), suggesting that this SBT is a precursor of HGSC, and that there may be a pathway from Type I to Type II ovarian cancer [14]. This evidence concerns the gene TP53 and neoplasm.